Tetraphase Pharmaceuticals, Inc. (TTPH) Financial Statements (2024 and earlier)
Company Profile
Business Address |
480 ARSENAL WAY WATERTOWN, MA 02472 |
State of Incorp. | DE |
Fiscal Year End | December 31 |
Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
3/31/2020 MRQ | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 21,239 | 107,776 | 136,411 | 142,086 | 205,912 | 121,042 | |||
Cash and cash equivalents | 21,239 | 107,776 | 136,411 | 142,086 | 205,912 | 121,042 | |||
Receivables | 1,503 | 2,274 | 4,653 | 1,789 | 4,151 | 3,458 | |||
Inventory, net of allowances, customer advances and progress billings | 1,595 | 748 | |||||||
Inventory | 1,595 | 748 | |||||||
Contract with customer, asset, after allowance for credit loss | 3,000 | ✕ | ✕ | ✕ | ✕ | ||||
Asset, held-for-sale, not part of disposal group | 53 | ✕ | |||||||
Other undisclosed current assets | 2,103 | 2,674 | 6,382 | 6,582 | 3,705 | 2,097 | |||
Total current assets: | 26,493 | 116,472 | 147,446 | 150,457 | 213,768 | 126,597 | |||
Noncurrent Assets | |||||||||
Operating lease, right-of-use asset | 4,836 | ✕ | ✕ | ✕ | ✕ | ✕ | |||
Property, plant and equipment | 98 | 1,121 | 1,395 | 1,054 | 943 | 300 | |||
Intangible assets, net (including goodwill), including: | 4,259 | 4,652 | |||||||
Other undisclosed intangible assets, net (including goodwill) | 4,259 | 4,652 | |||||||
Restricted cash and investments | 699 | 699 | 199 | 199 | 199 | 199 | |||
Other noncurrent assets | 7 | 108 | |||||||
Total noncurrent assets: | 9,892 | 6,472 | 1,594 | 1,253 | 1,149 | 607 | |||
TOTAL ASSETS: | 36,385 | 122,944 | 149,040 | 151,710 | 214,917 | 127,204 | |||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities | 8,223 | 14,957 | 17,865 | 10,240 | 9,788 | 15,940 | |||
Employee-related liabilities | 2,358 | ||||||||
Accounts payable | 2,429 | 3,210 | 5,306 | 2,555 | 2,857 | 4,105 | |||
Accrued liabilities | 5,794 | 11,747 | 12,559 | 7,685 | 6,931 | 9,477 | |||
Debt | 1,547 | 3,436 | |||||||
Deferred revenue and credits | ✕ | ✕ | ✕ | 660 | 1,255 | 909 | 258 | ||
Contract with customer, liability | ✕ | ✕ | 6 | ✕ | ✕ | ✕ | ✕ | ||
Other undisclosed current liabilities | (2,358) | ||||||||
Total current liabilities: | 9,770 | 14,963 | 18,525 | 11,495 | 10,697 | 17,276 | |||
Noncurrent Liabilities | |||||||||
Long-term debt and lease obligation | 3,448 | 28,291 | 1,124 | ||||||
Long-term debt, excluding current maturities | 28,291 | 1,124 | |||||||
Liabilities, other than long-term debt | 8 | 105 | 162 | 165 | 16 | ||||
Deferred revenue and credits | ✕ | ✕ | ✕ | 165 | 16 | ||||
Other liabilities | 8 | 105 | 162 | ||||||
Operating lease, liability | 3,448 | ✕ | ✕ | ✕ | ✕ | ✕ | |||
Total noncurrent liabilities: | 3,448 | 28,299 | 105 | 162 | 165 | 1,140 | |||
Total liabilities: | 13,218 | 43,262 | 18,630 | 11,657 | 10,862 | 18,416 | |||
Equity | |||||||||
Equity, attributable to parent | 23,167 | 79,682 | 130,410 | 140,053 | 204,055 | 108,566 | |||
Common stock | 3 | 53 | 51 | 37 | 37 | 31 | |||
Additional paid in capital | 627,291 | 613,671 | 592,243 | 487,148 | 473,670 | 294,998 | |||
Accumulated deficit | (604,127) | (534,042) | (461,884) | (347,132) | (269,652) | (186,463) | |||
Total equity: | 23,167 | 79,682 | 130,410 | 140,053 | 204,055 | 108,566 | |||
Other undisclosed liabilities and equity | 222 | ||||||||
TOTAL LIABILITIES AND EQUITY: | 36,385 | 122,944 | 149,040 | 151,710 | 214,917 | 127,204 |
Income Statement (P&L) ($ in thousands)
3/31/2020 TTM | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 7,376 | 18,904 | 9,666 | 5,145 | 11,686 | 9,098 | ||
Gross profit: | 7,376 | 18,904 | 9,666 | 5,145 | 11,686 | 9,098 | ||
Operating expenses | (74,908) | (92,185) | (125,381) | (82,975) | (94,684) | (87,798) | ||
Other undisclosed operating income | 12,934 | |||||||
Operating loss: | (67,532) | (73,281) | (115,715) | (77,830) | (82,998) | (65,766) | ||
Nonoperating income (expense) | 1,595 | 1,747 | 963 | 350 | (191) | (976) | ||
Investment income, nonoperating | 1,262 | 1,747 | 350 | 42 | 17 | |||
Other nonoperating income (expense) | 333 | 963 | (2) | 24 | ||||
Interest and debt expense | (4,148) | (624) | (231) | (1,017) | ||||
Other undisclosed income from continuing operations before equity method investments, income taxes | 83,337 | |||||||
Loss from continuing operations: | (70,085) | (72,158) | (114,752) | (77,480) | (83) | (67,759) | ||
Loss before gain (loss) on sale of properties: | (70,185) | (72,158) | (114,752) | (77,480) | (83) | (67,759) | ||
Loss from discontinued operations | (100) | |||||||
Net loss: | (70,185) | (72,158) | (114,752) | (77,480) | (83) | (67,759) | ||
Other undisclosed net income (loss) attributable to parent | 100 | (83,106) | 1,017 | |||||
Net loss available to common stockholders, diluted: | (70,085) | (72,158) | (114,752) | (77,480) | (83,189) | (66,742) |
Comprehensive Income ($ in thousands)
3/31/2020 TTM | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | ||
---|---|---|---|---|---|---|---|---|
Net loss: | (70,185) | (72,158) | (114,752) | (77,480) | (83) | (67,759) | ||
Comprehensive loss: | (70,185) | (72,158) | (114,752) | (77,480) | (83) | (67,759) | ||
Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 100 | (83,106) | 1,017 | |||||
Comprehensive loss, net of tax, attributable to parent: | (70,085) | (72,158) | (114,752) | (77,480) | (83,189) | (66,742) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.